Stay updated on Pediatric Fremanezumab for Episodic Migraine Clinical Trial
Sign up to get notified when there's something new on the Pediatric Fremanezumab for Episodic Migraine Clinical Trial page.

Latest updates to the Pediatric Fremanezumab for Episodic Migraine Clinical Trial page
- Check2 days agoChange DetectedRevision 3.3.4 is added to the page history, replacing 3.3.3. This is a UI/version update and does not change study content.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision: v3.3.3 was added to the record history. The HHS Vulnerability Disclosure link and the Revision: v3.3.2 entry were removed.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision history shows an addition of v3.3.2 and removal of v3.2.0 in the page footer, reflecting a minor site version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check60 days agoChange DetectedRemoved the government funding operating status notice from the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check74 days agoChange DetectedNew versions show updates to the study status and related sections such as recruitment and Contacts/Locations. These changes reflect ongoing updates to the trial record.SummaryDifference0.0%

- Check103 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference8%

Stay in the know with updates to Pediatric Fremanezumab for Episodic Migraine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Fremanezumab for Episodic Migraine Clinical Trial page.